Amarin Corporation PLC KOL Webinar Transcript
Thank you all for joining what we believe will be a stimulating and useful discussion about key cardiovascular therapeutic data presented at this year's American Heart Association 2022 Scientific Sessions and their impact on patient care in both the United States and Europe. We know you are very busy, and we are grateful for your perspectives and input on data presented at the AHA Scientific Sessions. I'm Dr. Steven Ketchum, Executive Vice President, President of R&D and Chief Scientific Officer at Amarin.
And I'm Nabil Abadir, I'm the Senior Vice President and Chief Medical Officer at Amarin. Turning to our panel. Can I ask each of our participant to please briefly introduce yourself, starting with Dr. Cory?
Good morning, everyone. I'm Dr. Payal Kohli. I'm a noninvasive
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |